
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Avidity Biosciences Inc is a biotechnology company. The company develops novel Antibody Oligonucleotide Conjugates therapies designed to overcome the current limitations of oligonucleotide therapies in order to treat a wide range of serious diseases. Its product candidate AOC 1001, is designed to tr... Avidity Biosciences Inc is a biotechnology company. The company develops novel Antibody Oligonucleotide Conjugates therapies designed to overcome the current limitations of oligonucleotide therapies in order to treat a wide range of serious diseases. Its product candidate AOC 1001, is designed to treat a rare monogenic muscle disease. Show more
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 1.525 | 5.30158178342 | 28.765 | 31 | 27.6427 | 1511389 | 29.71331959 | CS |
4 | -4.78 | -13.629883091 | 35.07 | 35.53 | 27.6427 | 1370271 | 31.3442073 | CS |
12 | -3.46 | -10.2518518519 | 33.75 | 35.53 | 26.74 | 1367699 | 31.05838994 | CS |
26 | -10.71 | -26.1219512195 | 41 | 56 | 26.74 | 1301795 | 38.02722617 | CS |
52 | 10.23 | 50.9970089731 | 20.06 | 56 | 19.24 | 1329083 | 36.4702844 | CS |
156 | 14.32 | 89.6681277395 | 15.97 | 56 | 4.825 | 1094583 | 22.97522981 | CS |
260 | 11.64 | 62.4128686327 | 18.65 | 56 | 4.825 | 788968 | 23.13505795 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions